Suchergebnisse - "Bines, José"

PubPharm (85)

1

Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer : The BrasiLEEira Study

enthalten in: JCO global oncology | 2024

von Suzuki, D. | Morelle, A. | de Brito, M. | +12

2

Nuclear and Cytoplasmic hTERT, Tumor-Infiltrating Lymphocytes, and Telomere Elongation Leukocytes Are Independent Factors in the Response to Neoadjuvant Treatment in HER2-Enriched Breast Cancer

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Delmonico, L. | Bines, J. | Nascimento, C. | +8

3

Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Asleh, K. | Lluch, A. | Goytain, A. | +18

4

Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage : a sub analysis of the AMAZONA III Study (GBECAM 0115)

enthalten in: Breast cancer research and treatment | 2023

von Maschmann, R. | De Jesus, R. | Werutsky, G. | +6

5

Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III Study (GBECAM 0115)

enthalten in: Breast cancer research and treatment | 2022

von Maschmann, R. | De Jesus, R. | Werutsky, G. | +6

6

Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III Study (GBECAM 0115)

enthalten in: Breast cancer research and treatment | 2022

von Maschmann, R. | De Jesus, R. | Werutsky, G. | +6

7

Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III Study (GBECAM 0115)

enthalten in: Breast cancer research and treatment | 2022

von Maschmann, R. | De Jesus, R. | Werutsky, G. | +6

8

Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy

enthalten in: Journal of the National Cancer Institute | 2022

von Lambertini, M. | Fielding, S. | Loibl, S. | +19

9

Is there a window of opportunity to optimize trastuzumab cardiac monitoring?

enthalten in: World journal of cardiology | 2022

von Rala de Paula, B. | Costa, M. | de Sousa, C. | +1

10

Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast Brazil

enthalten in: The oncologist | 2022

von Shafaee, M. | Silva, L. | Ramalho, S. | +22

1
2
3
4
5
6
7
8
9
Nächster »
[9]